BIO (March 2025)/ XFTTBIOCMEGL / CME EMini
BIO| - - | Chg. - | Open | High | Low | Previous Close |
|---|---|---|---|---|---|
| -USD | - | - | - | - | - |
Newsfile Corp
1:38 AM
BLUE LOSS ALERT: TOP RANKED ROSEN LAW FIRM Encourages bluebird bio Inc. Investors to Inquire About S...
GlobeNewswire
04-26
Robbins LLP Reminds Investors of Bluebird Bio, Inc. to Contact the Law Firm for Information About th...
GlobeNewswire
04-26
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Agains...
GlobeNewswire
04-26
BLUE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that bluebird bio, Inc. Investors w...
GlobeNewswire
04-26
Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiativ...
GlobeNewswire
04-25
GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
GlobeNewswire
04-24
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses o...
GlobeNewswire
04-24
noco-noco Collaborates with Binex to Develop Agriculture Based, Soil Sequestered Carbon into Credits
GlobeNewswire
04-23
BLUE INVESTOR NOTICE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages bluebird bio Inc. Investors to Inqui...
GlobeNewswire
04-23
Epic Bio Presents New Data Highlighting Potential of EPI-321 for FSHD and Epigenetic Editing Platfor...
GlobeNewswire
04-21
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Secure Counsel Before Imp...
GlobeNewswire
04-19
Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-M...
GlobeNewswire
04-18
ROSEN, A TOP RANKED LAW FIRM, Encourages bluebird bio Inc. Investors to Inquire About Securities Cla...
GlobeNewswire
04-18
Barinthus Bio Announces Topline Data from Phase 1b/2 APOLLO Trial of VTP-200 in Persistent High-Risk...
GlobeNewswire
04-18
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under...
GlobeNewswire
04-18
Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS...
GlobeNewswire
04-18
Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinica...
GlobeNewswire
04-17
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Befor...
GlobeNewswire
04-16
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses...
GlobeNewswire
04-16
Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy...
GlobeNewswire
04-16
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages bluebird bio Inc. Investors to Inquire About S...
GlobeNewswire
04-12
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Secure Counsel Before ...
GlobeNewswire
04-11
Syntekabio to Showcase Innovative AI Drug Discovery Technologies at Bio-IT World
